|
M & A Research Institute Holdings Inc. (9552.t) DCF -Bewertung
JP | Financial Services | Financial - Capital Markets | JPX
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
M&A Research Institute Holdings Inc. (9552.T) Bundle
Verbessern Sie Ihre Investitionsauswahl mit dem DCF -Taschenrechner des M & A Research Institute Holdings Inc. (9552T)! Erforschen Sie authentische Finanzdaten, passen Sie Wachstumsprojektionen und -kosten an und beobachten Sie, wie sich diese Modifikationen in Echtzeit auf den inneren Wert des M & A Research Institute Holdings Inc. (9552T) auswirken.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 376.0 | 1,328.0 | 3,911.6 | 8,642.5 | 16,549.6 | 32,747.1 | 64,797.6 | 128,216.8 | 253,706.0 | 502,014.8 |
| Revenue Growth, % | 0 | 253.18 | 194.54 | 120.95 | 91.49 | 97.87 | 97.87 | 97.87 | 97.87 | 97.87 |
| EBITDA | 6.7 | 563.1 | 2,097.8 | 4,605.2 | 8,462.5 | 13,245.2 | 26,208.6 | 51,859.6 | 102,616.0 | 203,049.0 |
| EBITDA, % | 1.78 | 42.4 | 53.63 | 53.29 | 51.13 | 40.45 | 40.45 | 40.45 | 40.45 | 40.45 |
| Depreciation | 2.4 | 4.9 | 14.8 | 26.0 | 57.3 | 133.8 | 264.7 | 523.8 | 1,036.4 | 2,050.7 |
| Depreciation, % | 0.64676 | 0.37077 | 0.37816 | 0.30054 | 0.34621 | 0.40849 | 0.40849 | 0.40849 | 0.40849 | 0.40849 |
| EBIT | 4.3 | 558.2 | 2,083.0 | 4,579.3 | 8,405.2 | 13,111.4 | 25,943.9 | 51,335.9 | 101,579.6 | 200,998.3 |
| EBIT, % | 1.13 | 42.03 | 53.25 | 52.99 | 50.79 | 40.04 | 40.04 | 40.04 | 40.04 | 40.04 |
| Total Cash | 556.0 | 1,177.3 | 3,981.3 | 7,430.4 | 10,174.7 | 28,562.4 | 56,517.2 | 111,832.0 | 221,284.9 | 437,862.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 19.2 | 53.9 | 9.9 | 143.2 | 371.5 | 872.4 | 1,726.3 | 3,415.8 | 6,758.9 | 13,374.0 |
| Account Receivables, % | 5.11 | 4.06 | 0.25353 | 1.66 | 2.24 | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 |
| Inventories | 1.7 | 13.5 | 39.7 | .0 | .0 | 162.7 | 322.0 | 637.2 | 1,260.8 | 2,494.8 |
| Inventories, % | 0.45236 | 1.02 | 1.02 | 0 | 0 | 0.49695 | 0.49695 | 0.49695 | 0.49695 | 0.49695 |
| Accounts Payable | 19.0 | 28.5 | .0 | .0 | .0 | 470.9 | 931.8 | 1,843.7 | 3,648.3 | 7,218.9 |
| Accounts Payable, % | 5.04 | 2.15 | 0 | 0 | 0 | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 |
| Capital Expenditure | -3.8 | -25.5 | -15.9 | -62.9 | -156.4 | -328.9 | -650.8 | -1,287.8 | -2,548.3 | -5,042.4 |
| Capital Expenditure, % | -1.02 | -1.92 | -0.40758 | -0.72755 | -0.9453 | -1 | -1 | -1 | -1 | -1 |
| Tax Rate, % | 31.12 | 31.12 | 31.12 | 31.12 | 31.12 | 31.12 | 31.12 | 31.12 | 31.12 | 31.12 |
| EBITAT | 4.6 | 368.3 | 1,326.8 | 2,702.8 | 5,789.5 | 9,377.0 | 18,554.4 | 36,714.1 | 72,647.2 | 143,749.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 1.3 | 310.8 | 1,314.9 | 2,572.3 | 5,462.1 | 8,989.0 | 17,616.0 | 34,857.3 | 68,973.1 | 136,478.8 |
| WACC, % | 7.84 | 7.84 | 7.84 | 7.84 | 7.84 | 7.84 | 7.84 | 7.84 | 7.84 | 7.84 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 195,845.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 139,208 | |||||||||
| Terminal Value | 2,383,308 | |||||||||
| Present Terminal Value | 1,634,034 | |||||||||
| Enterprise Value | 1,829,879 | |||||||||
| Net Debt | -10,116 | |||||||||
| Equity Value | 1,839,995 | |||||||||
| Diluted Shares Outstanding, MM | 64 | |||||||||
| Equity Value Per Share | 28,748.59 |
What You Will Receive
- Comprehensive Financial Model: Utilize M&A Research Institute Holdings Inc.'s (9552T) actual data for accurate DCF valuation.
- Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other critical factors as needed.
- Real-Time Calculations: Automatic updates let you view results instantly as you adjust inputs.
- Professional-Grade Template: A polished Excel file crafted for serious valuation analysis.
- Adaptable and Reusable: Designed for versatility, allowing for repeated application in detailed forecasts.
Key Features
- 🔍 Real-Life M&A Research Institute Holdings Financials: Pre-filled historical and projected data for M&A Research Institute Holdings Inc. (9552T).
- ✏️ Fully Customizable Inputs: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Integrated formulas calculate the intrinsic value of M&A Research Institute Holdings using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize the valuation of M&A Research Institute Holdings immediately after making adjustments.
- Scenario Analysis: Evaluate and compare outcomes for different financial assumptions side-by-side.
How It Works
- Download the Template: Gain immediate access to the Excel-based M&A Research Institute Holdings Inc. DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model will automatically refresh M&A Research Institute Holdings Inc.'s intrinsic value.
- Test Scenarios: Explore different assumptions to assess potential valuation fluctuations.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis for M&A Research Institute Holdings Inc. (9552T).
Why Choose This Calculator for M&A Research Institute Holdings Inc. (9552T)?
- Tailored for Experts: A sophisticated tool designed for analysts, M&A professionals, and investment advisors.
- Comprehensive Data: M&A Research Institute Holdings Inc.'s historical and projected financials are integrated for precise analysis.
- Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions to gauge potential outcomes.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and essential financial indicators.
- User-Friendly Interface: Clear, step-by-step guidance to facilitate your calculations.
Who Can Benefit from This Product?
- Professional Investors: Develop comprehensive and reliable valuation models for M&A analysis.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decision-making.
- Consultants and Advisors: Deliver precise valuation assessments for M&A opportunities involving M&A Research Institute Holdings Inc. (9552T).
- Students and Educators: Utilize real-world data to enhance financial modeling skills and knowledge.
- Industry Enthusiasts: Gain insights into how companies like M&A Research Institute Holdings Inc. (9552T) are valued within the market.
Contents of the Template
- Pre-Filled Data: Contains historical financials and forecasts for M&A Research Institute Holdings Inc. (9552T).
- Discounted Cash Flow Model: An editable DCF valuation model featuring automatic calculations.
- Weighted Average Cost of Capital (WACC): A specific sheet designed for calculating WACC using custom inputs.
- Key Financial Ratios: Evaluate M&A Research Institute Holdings Inc. (9552T)’s profitability, efficiency, and leverage.
- Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
- Clear Dashboard: Visualizations and tables that summarize essential valuation outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.